Global Health Innovation Network unites Singapore and Sweden in pioneering healthcare advancement
The aim is to accelerate the development and implementation of scalable healthcare solutions that improve global health outcomes.
The Singapore National University Health System (NUHS), Sweden Sahlgrenska University Hospital, AstraZeneca, and Business Sweden are partnering through the Global Health Innovation Network (GHIN) to advance global healthcare innovation. That strategic initiative, therefore, aims to drive progress in screening, diagnosis, and monitoring technologies by combining expertise from the healthcare, pharmaceutical, and technology sectors.
Specifically, NUHS and Sahlgrenska University Hospital will provide clinical expertise, hospital resources, and research collaboration, while AstraZeneca, Ericsson, and Business Sweden will contribute their strengths in pharmaceutical innovation, technological connectivity, and project management. The partnership was formalised by signing a Memorandum of Understanding (MoU) at the Singapore-Sweden Royal Business Forum, marking the first project under the government-to-government MoU on healthcare innovation between Singapore and Sweden.
As a result, GHIN’s goal is to accelerate the development and global implementation of innovative healthcare solutions, addressing the evolving needs of healthcare systems worldwide. By bringing together diverse industry leaders, the initiative aims to improve healthcare outcomes globally and ensure that both technological and clinical advancements are integrated into scalable solutions. Ultimately, this collaboration is set to make cutting-edge healthcare innovations more accessible to populations worldwide.